Schedule 13G ownership disclosure
Caris Life Sciences Inc
Common Stock, par value $0.001 per share · CUSIP: 142152107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- TSSP Sub-Fund HoldCo, LLC
Shares: 18,416,128.00 · Class: 6.5%
- Alan Waxman
Shares: 19,385,399.00 · Class: 6.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-26-051538
- Form type
- SCHEDULE 13G/A
- Filer
- Caris Life Sciences, Inc.
- CIK
- CIK 2019410
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership